Drugs / Northern Hemisphere Influenza Vaccine 2017/18
Northern Hemisphere Influenza Vaccine 2017/18
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03144518 Background | Sep → Nov 2017 | — | University of Nottingham | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Northern Hemisphere Influenza Vaccine 2017/18 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03144518 ↗ |
| Modality | Vaccine | “Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)” NCT03144518 ↗ |